About this trial
This clinical trial evaluates the effectiveness of a conversation tool on patient-centered health and decision-making outcomes in patients with lung cancer making treatment decisions. This research is being conducted to help doctors understand the information patients need to participate in shared decision-making about their lung cancer treatment options. The focus of this research is to study how patients choose lung cancer treatment options and the information needed to make that choice, with a focus on patients with lower health literacy.
Eligibility criteria
Qualifiers
AIM 1: Suspected lung cancer
AIM 1: English fluency
AIM 1: > 6-month life expectancy
AIM 1: Score of ≥ 3 on the cognitive impairment screener
Disqualifiers
None
Trial design
Treatments tested in this trial
- Best Practice
- Health Promotion and Education
- Questionnaire Administration
Treatment groups
Sponsors and collaborators
OHSU Knight Cancer Institute
Lead sponsor
Oregon Health and Science University
Collaborator
American Cancer Society, Inc.
Collaborator